PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2149240
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2149240
Carrier Screening Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of carrier screening Market
The global carrier screening market size was valued at USD 1.70 billion in 2025 and is projected to grow from USD 1.88 billion in 2026 to USD 3.08 billion by 2034, registering a CAGR of 6.4% during the forecast period. North America dominated the global market with a 40% share in 2025. Carrier screening is a genetic testing approach used to identify individuals who carry genes associated with inherited disorders, even when they do not show symptoms. Increasing awareness of genetic diseases, rising demand for preconception and prenatal testing, and growing integration with fertility care are supporting market expansion.
The market is also benefiting from advances in next-generation sequencing (NGS), expanded carrier screening (ECS), and personalized medicine. According to the supplied report, approximately 7.9 million births globally, representing around 6% of annual births, occur with a genetic or partially genetic defect. Growing research and development activities and strategic initiatives by companies such as Natera, Labcorp, Quest Diagnostics, and Myriad Genetics are further increasing testing volumes.
Market Definition and Scope
Carrier screening identifies whether an individual carries a gene responsible for a recessive inherited condition and helps assess the potential risk of passing the condition to offspring. The market includes targeted disease carrier screening, expanded carrier screening, custom panels, NGS, PCR, microarray-based screening, blood and saliva samples, and services delivered through clinical laboratories, hospitals, and direct-to-consumer testing companies.
Market Dynamics
Driver - Technological Advancements and Rising Awareness: The adoption of NGS has reduced testing costs and enabled laboratories to screen multiple conditions through expanded gene panels. Updated professional guidelines, increasing IVF procedures, and greater awareness of conditions such as thalassemia, spinal muscular atrophy, and cystic fibrosis are supporting test adoption.
Restraint - High Testing Costs: Expanded carrier screening panels can cost approximately USD 250-600 in many regions. Limited insurance coverage, differences in reimbursement policies, inconsistent screening guidelines, and shortages of genetic counselors restrict adoption, particularly in developing markets.
Opportunity - Expansion into Emerging Markets: India, Brazil, Indonesia, and GCC countries offer growth opportunities as fertility treatments, genetic awareness, and government-backed screening programs expand. Integration of carrier screening with IVF and preconception care, AI-assisted variant interpretation, automated laboratory workflows, and partnerships between sequencing providers and fertility clinics are creating additional opportunities.
Trend - Shift Toward Expanded Multi-Gene Panels: The market is moving from targeted tests toward expanded multi-gene panels. At-home sample collection and saliva kits are also improving convenience and extending access to testing.
Challenge - Limited Diagnosis and Awareness: Delayed referrals, shortages of genetic expertise, and limited counseling capacity can restrict screening adoption. Ethical, legal, cultural, and genetic privacy concerns also create barriers to wider implementation.
Segmentation Analysis
By Type: Expanded carrier screening held the largest market share in 2025 due to its ability to assess hundreds of genes regardless of ethnicity or family history. Custom panel screening is projected to grow at a CAGR of 5.9%.
By Technology: NGS dominated with a 73.3% share in 2025, supported by declining sequencing costs and wider ECS panels. PCR is projected to grow at a CAGR of 6.0%.
By Indication: Hemoglobinopathies dominated in 2025 and are expected to hold a 28.9% share in 2026, supported by the prevalence of thalassemia and sickle cell disorders. The SMA segment is projected to grow at a CAGR of 7.1%.
By Sample Type: Blood dominated in 2025 and is expected to account for 73.7% in 2026, while saliva is projected to grow at a CAGR of 6.8%.
By Service Provider: Clinical laboratories led the market and are expected to hold a 57.0% share in 2026. DTC testing companies are projected to grow at a CAGR of 7.0%.
Regional Insights
North America: The region led the market with USD 0.68 billion in 2025 and is estimated to reach USD 0.72 billion in 2026, supported by advanced healthcare infrastructure, genetic testing adoption, and reimbursement coverage.
Europe: The market is projected to reach USD 0.50 billion in 2026, supported by NGS adoption, NHS and Genomics England initiatives, regulatory standards, and increasing testing volumes.
Asia Pacific: The region is expected to reach USD 0.34 billion in 2026, with India at USD 0.07 billion and China at USD 0.08 billion, supported by improving healthcare infrastructure and rising genetic awareness.
Latin America and Middle East & Africa: Latin America is projected to reach USD 0.16 billion in 2026, while GCC is expected to reach USD 0.06 billion, supported by healthcare modernization and growing awareness of genetic disorders.
Competitive Landscape
Major companies include Natera, Inc., Labcorp, Quest Diagnostics Incorporated, Myriad Genetics, Fulgent Genetics, BGI Group, Berry Genomics, Eurofins Scientific, CENTOGENE GmbH, YOURGENE HEALTH, and MedGenome. Companies are expanding through advanced screening portfolios, geographic expansion, acquisitions, and strategic partnerships.
Key Industry Developments
In October 2024, Yourgene Health received IVDR accreditation for its Cystic Fibrosis Base assay. In January 2024, Natera acquired reproductive health assets from Invitae. Ambry Genetics launched its CARE reproductive health program in October 2022, while Asuragen received FDA clearance for its Fragile X Dx and Carrier Screen Kit in February 2020.
Report Coverage
The report covers market size and forecast, segmentation by type, technology, indication, sample type, and service provider, regional analysis, competitive landscape, key companies, market dynamics, emerging trends, and major industry developments.
Conclusion
The global carrier screening market is expected to expand from USD 1.70 billion in 2025 to USD 1.88 billion in 2026 and USD 3.08 billion by 2034. Growth will be supported by NGS adoption, expanded multi-gene screening, rising genetic disease awareness, IVF integration, and expanding access to genetic testing. At the same time, testing costs, reimbursement gaps, shortages of genetic counseling professionals, and ethical and regulatory considerations will remain important market challenges. Expansion across emerging markets and continued development of AI-enabled and patient-centric screening services are expected to create further opportunities through the forecast period.
Segmentation By Type, Technology, Indication, Sample Type, Service Provider, and Region
By Type
- Targeted Disease Carrier Screening
- Expanded Carrier Screening (ECS)
- Custom Panel Screening
By Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray-based Screening
- Other Technologies
By Indication
- Hemoglobinopathies
- Cystic Fibrosis
- Spinal Muscular Atrophy (SMA)
- Fragile X
- Others
By Sample Type
- Blood
- Saliva
- Others
By Service Provider
- Clinical Laboratories
- Hospital Laboratories
- Direct-to-Consumer (DTC) Testing Companies
- Others
By Region North America (By Type, By Technology, By Indication, By Sample Type, By Service Provider, and by Country)
- U.S. (By Technology)
- Canada (By Technology)
Europe (By Type, By Technology, By Indication, By Sample Type, By Service Provider, and by Country/Sub-region)
- U.K. (By Technology)
- Germany (By Technology)
- France (By Technology)
- Italy (By Technology)
- Spain (By Technology)
- Scandinavia (By Technology)
- Rest of Europe (By Technology)
Asia Pacific (By Type, By Technology, By Indication, By Sample Type, By Service Provider, and by Country/Sub-region)
- China (By Technology)
- Japan (By Technology)
- India (By Technology)
- Australia (By Technology)
- Southeast Asia (By Technology)
- Rest of Asia Pacific (By Technology)
Latin America (By Type, By Technology, By Indication, By Sample Type, By Service Provider, and by Country/Sub-region)
- Brazil (By Technology)
- Mexico (By Technology)
- Rest of Latin America (By Technology)
Middle East & Africa (By Type, By Technology, By Indication, By Sample Type, By Service Provider, and by Country/Sub-region)
- GCC (By Technology)
- South Africa (By Technology)
- Rest of the Middle East & Africa (By Technology)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2025
- 4.2. Advancements in the Carrier Screening Market
- 4.3. New Service Launches, Key Players
- 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships
5. Global Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Targeted Disease Carrier Screening
- 5.1.2. Expanded Carrier Screening (ECS)
- 5.1.3. Custom Panel Screening
- 5.2. Market Analysis, Insights and Forecast - By Technology
- 5.2.1. Next-Generation Sequencing (NGS)
- 5.2.2. Polymerase Chain Reaction (PCR)
- 5.2.3. Microarray-based Screening
- 5.2.4. Other Technologies
- 5.3. Market Analysis, Insights and Forecast - By Indication
- 5.3.1. Hemoglobinopathies
- 5.3.2. Cystic Fibrosis
- 5.3.3. Spinal Muscular Atrophy (SMA)
- 5.3.4. Fragile X
- 5.3.5. Others
- 5.4. Market Analysis, Insights and Forecast - By Sample Type
- 5.4.1. Blood
- 5.4.2. Saliva
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - By Service Provider
- 5.5.1. Clinical Laboratories
- 5.5.2. Hospital Laboratories
- 5.5.3. Direct-to-Consumer (DTC) Testing Companies
- 5.5.4. Others
- 5.6. Market Analysis, Insights and Forecast - By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
6. North America Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Targeted Disease Carrier Screening
- 6.1.2. Expanded Carrier Screening (ECS)
- 6.1.3. Custom Panel Screening
- 6.2. Market Analysis, Insights and Forecast - By Technology
- 6.2.1. Next-Generation Sequencing (NGS)
- 6.2.2. Polymerase Chain Reaction (PCR)
- 6.2.3. Microarray-based Screening
- 6.2.4. Other Technologies
- 6.3. Market Analysis, Insights and Forecast - By Indication
- 6.3.1. Hemoglobinopathies
- 6.3.2. Cystic Fibrosis
- 6.3.3. Spinal Muscular Atrophy (SMA)
- 6.3.4. Fragile X
- 6.3.5. Others
- 6.4. Market Analysis, Insights and Forecast - By Sample Type
- 6.4.1. Blood
- 6.4.2. Saliva
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast - By Service Provider
- 6.5.1. Clinical Laboratories
- 6.5.2. Hospital Laboratories
- 6.5.3. Direct-to-Consumer (DTC) Testing Companies
- 6.5.4. Others
- 6.6. Market Analysis, Insights and Forecast - By Country
- 6.6.1. U.S.
- 6.6.1.1. By Technology
- 6.6.2. Canada
- 6.6.2.1. By Technology
- 6.6.1. U.S.
7. Europe Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Targeted Disease Carrier Screening
- 7.1.2. Expanded Carrier Screening (ECS)
- 7.1.3. Custom Panel Screening
- 7.2. Market Analysis, Insights and Forecast - By Technology
- 7.2.1. Next-Generation Sequencing (NGS)
- 7.2.2. Polymerase Chain Reaction (PCR)
- 7.2.3. Microarray-based Screening
- 7.2.4. Other Technologies
- 7.3. Market Analysis, Insights and Forecast - By Indication
- 7.3.1. Hemoglobinopathies
- 7.3.2. Cystic Fibrosis
- 7.3.3. Spinal Muscular Atrophy (SMA)
- 7.3.4. Fragile X
- 7.3.5. Others
- 7.4. Market Analysis, Insights and Forecast - By Sample Type
- 7.4.1. Blood
- 7.4.2. Saliva
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast - By Service Provider
- 7.5.1. Clinical Laboratories
- 7.5.2. Hospital Laboratories
- 7.5.3. Direct-to-Consumer (DTC) Testing Companies
- 7.5.4. Others
- 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.6.1. U.K.
- 7.6.1.1. By Technology
- 7.6.2. Germany
- 7.6.2.1. By Technology
- 7.6.3. France
- 7.6.3.1. By Technology
- 7.6.4. Spain
- 7.6.4.1. By Technology
- 7.6.5. Italy
- 7.6.5.1. By Technology
- 7.6.6. Scandinavia
- 7.6.6.1. By Technology
- 7.6.7. Rest of Europe
- 7.6.7.1. By Technology
- 7.6.1. U.K.
8. Asia Pacific Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Targeted Disease Carrier Screening
- 8.1.2. Expanded Carrier Screening (ECS)
- 8.1.3. Custom Panel Screening
- 8.2. Market Analysis, Insights and Forecast - By Technology
- 8.2.1. Next-Generation Sequencing (NGS)
- 8.2.2. Polymerase Chain Reaction (PCR)
- 8.2.3. Microarray-based Screening
- 8.2.4. Other Technologies
- 8.3. Market Analysis, Insights and Forecast - By Indication
- 8.3.1. Hemoglobinopathies
- 8.3.2. Cystic Fibrosis
- 8.3.3. Spinal Muscular Atrophy (SMA)
- 8.3.4. Fragile X
- 8.3.5. Others
- 8.4. Market Analysis, Insights and Forecast - By Sample Type
- 8.4.1. Blood
- 8.4.2. Saliva
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast - By Service Provider
- 8.5.1. Clinical Laboratories
- 8.5.2. Hospital Laboratories
- 8.5.3. Direct-to-Consumer (DTC) Testing Companies
- 8.5.4. Others
- 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.6.1. Japan
- 8.6.1.1. By Technology
- 8.6.2. Australia
- 8.6.2.1. By Technology
- 8.6.3. China
- 8.6.3.1. By Technology
- 8.6.4. India
- 8.6.4.1. By Technology
- 8.6.5. Southeast Asia
- 8.6.5.1. By Technology
- 8.6.6. Rest of Asia Pacific
- 8.6.6.1. By Technology
- 8.6.1. Japan
9. Latin America Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Targeted Disease Carrier Screening
- 9.1.2. Expanded Carrier Screening (ECS)
- 9.1.3. Custom Panel Screening
- 9.2. Market Analysis, Insights and Forecast - By Technology
- 9.2.1. Next-Generation Sequencing (NGS)
- 9.2.2. Polymerase Chain Reaction (PCR)
- 9.2.3. Microarray-based Screening
- 9.2.4. Other Technologies
- 9.3. Market Analysis, Insights and Forecast - By Indication
- 9.3.1. Hemoglobinopathies
- 9.3.2. Cystic Fibrosis
- 9.3.3. Spinal Muscular Atrophy (SMA)
- 9.3.4. Fragile X
- 9.3.5. Others
- 9.4. Market Analysis, Insights and Forecast - By Sample Type
- 9.4.1. Blood
- 9.4.2. Saliva
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast - By Service Provider
- 9.5.1. Clinical Laboratories
- 9.5.2. Hospital Laboratories
- 9.5.3. Direct-to-Consumer (DTC) Testing Companies
- 9.5.4. Others
- 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.6.1. Brazil
- 9.6.1.1. By Technology
- 9.6.2. Mexico
- 9.6.2.1. By Technology
- 9.6.3. Rest of Latin America
- 9.6.3.1. By Technology
- 9.6.1. Brazil
10. Middle East & Africa Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Targeted Disease Carrier Screening
- 10.1.2. Expanded Carrier Screening (ECS)
- 10.1.3. Custom Panel Screening
- 10.2. Market Analysis, Insights and Forecast - By Technology
- 10.2.1. Next-Generation Sequencing (NGS)
- 10.2.2. Polymerase Chain Reaction (PCR)
- 10.2.3. Microarray-based Screening
- 10.2.4. Other Technologies
- 10.3. Market Analysis, Insights and Forecast - By Indication
- 10.3.1. Hemoglobinopathies
- 10.3.2. Cystic Fibrosis
- 10.3.3. Spinal Muscular Atrophy (SMA)
- 10.3.4. Fragile X
- 10.3.5. Others
- 10.4. Market Analysis, Insights and Forecast - By Sample Type
- 10.4.1. Blood
- 10.4.2. Saliva
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast - By Service Provider
- 10.5.1. Clinical Laboratories
- 10.5.2. Hospital Laboratories
- 10.5.3. Direct-to-Consumer (DTC) Testing Companies
- 10.5.4. Others
- 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.6.1. GCC
- 10.6.1.1. By Technology
- 10.6.2. South Africa
- 10.6.2.1. By Technology
- 10.6.3. Rest of Middle East & Africa
- 10.6.3.1. By Technology
- 10.6.1. GCC
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2024)
- 11.2. Company Profiles
- 11.2.1. Natera, Inc.
- 11.2.2. Labcorp
- 11.2.3. Quest Diagnostics Incorporated.
- 11.2.4. Myriad Genetics, Inc.
- 11.2.5. Fulgent Genetics
- 11.2.6. BGI Group
- 11.2.7. Berry Genomics
- 11.2.8. Eurofins Scientific
- 11.2.9. CENTOGENE GmbH
- 11.2.10. YOURGENE HEALTH
- 11.2.11. MedGenome
List of Tables
- Table 1: Global Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 2: Global Carrier Screening Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 3: Global Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021-2034
- Table 4: Global Carrier Screening Market Revenue (USD billion) Forecast, by Sample Type, 2021-2034
- Table 5: Global Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021-2034
- Table 6: Global Carrier Screening Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 7: North America Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 8: North America Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 9: North America Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021-2034
- Table 10: North America Carrier Screening Market Revenue (USD billion) Forecast, by Sample Type, 2021-2034
- Table 11: North America Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021-2034
- Table 12: North America Carrier Screening Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 13: U.S. Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 14: Canada Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 15: Europe Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 16: Europe Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 17: Europe Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021-2034
- Table 18: Europe Carrier Screening Market Revenue (USD billion) Forecast, by Sample Type, 2021-2034
- Table 19: Europe Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021-2034
- Table 20: Europe Carrier Screening Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 21: Germany Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 22: U.K. Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 23: France Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 24: Italy Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 25: Spain Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 26: Scandinavia Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 27: Rest of Europe Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 28: Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 29: Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 30: Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021-2034
- Table 31: Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021-2034
- Table 32: Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 33: China Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 34: Japan Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 35: India Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 36: Australia Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 37: Southeast Asia Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 38: Rest of Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 39: Latin America Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 40: Latin America Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 41: Latin America Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021-2034
- Table 42: Latin America Carrier Screening Market Revenue (USD billion) Forecast, by Sample Type, 2021-2034
- Table 43: Latin America Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021-2034
- Table 44: Latin America Carrier Screening Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 45: Brazil Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 46: Mexico Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 47: Rest of Latin America Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 48: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 49: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 50: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021-2034
- Table 51: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, by Sample Type, 2021-2034
- Table 52: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021-2034
- Table 53: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 54: GCC Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 55: South Africa Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
- Table 56: Rest of Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021-2034
List of Figures
- Figure 1: Global Carrier Screening Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Carrier Screening Market Value Share (%), by Type, 2025 & 2034
- Figure 3: Global Carrier Screening Market Value Share (%), By Technology, 2025 & 2034
- Figure 4: Global Carrier Screening Market Value Share (%), by Indication, 2025 & 2034
- Figure 5: Global Carrier Screening Market Value Share (%), by Sample Type, 2025 & 2034
- Figure 6: Global Carrier Screening Market Value Share (%), by Service Provider, 2025 & 2034
- Figure 7: Global Carrier Screening Market Value Share (%), by Region, 2025 & 2034
- Figure 8: North America Carrier Screening Market Value (USD billion), by Type, 2025 & 2034
- Figure 9: North America Carrier Screening Market Value Share (%), by Type, 2025
- Figure 10: North America Carrier Screening Market Value (USD billion), By Technology, 2025 & 2034
- Figure 11: North America Carrier Screening Market Value Share (%), By Technology, 2025
- Figure 12: North America Carrier Screening Market Value (USD billion), by Indication, 2025 & 2034
- Figure 13: North America Carrier Screening Market Value Share (%), by Indication, 2025
- Figure 14: North America Carrier Screening Market Value (USD billion), by Sample Type, 2025 & 2034
- Figure 15: North America Carrier Screening Market Value Share (%), by Sample Type, 2025
- Figure 16: North America Carrier Screening Market Value (USD billion), by Service Provider, 2025 & 2034
- Figure 17: North America Carrier Screening Market Value Share (%), by Service Provider, 2025
- Figure 18: North America Carrier Screening Market Value (USD billion), By Country, 2025 & 2034
- Figure 19: North America Carrier Screening Market Value Share (%), By Country, 2025
- Figure 20: Europe Carrier Screening Market Value (USD billion), by Type, 2025 & 2034
- Figure 21: Europe Carrier Screening Market Value Share (%), by Type, 2025
- Figure 22: Europe Carrier Screening Market Value (USD billion), By Technology, 2025 & 2034
- Figure 23: Europe Carrier Screening Market Value Share (%), By Technology, 2025
- Figure 24: Europe Carrier Screening Market Value (USD billion), by Indication, 2025 & 2034
- Figure 25: Europe Carrier Screening Market Value Share (%), by Indication, 2025
- Figure 26: Europe Carrier Screening Market Value (USD billion), by Sample Type, 2025 & 2034
- Figure 27: Europe Carrier Screening Market Value Share (%), by Sample Type, 2025
- Figure 28: Europe Carrier Screening Market Value (USD billion), by Service Provider, 2025 & 2034
- Figure 29: Europe Carrier Screening Market Value Share (%), by Service Provider, 2025
- Figure 30: Europe Carrier Screening Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 31: Europe Carrier Screening Market Value Share (%), By Country/ Sub-region, 2025
- Figure 32: Asia Pacific Carrier Screening Market Value (USD billion), by Type, 2025 & 2034
- Figure 33: Asia Pacific Carrier Screening Market Value Share (%), by Type, 2025
- Figure 34: Asia Pacific Carrier Screening Market Value (USD billion), By Technology, 2025 & 2034
- Figure 35: Asia Pacific Carrier Screening Market Value Share (%), By Technology, 2025
- Figure 36: Asia Pacific Carrier Screening Market Value (USD billion), by Indication, 2025 & 2034
- Figure 37: Asia Pacific Carrier Screening Market Value Share (%), by Indication, 2025
- Figure 38: Asia Pacific Carrier Screening Market Value (USD billion), by Sample Type, 2025 & 2034
- Figure 39: Asia Pacific Carrier Screening Market Value Share (%), by Sample Type, 2025
- Figure 40: Asia Pacific Carrier Screening Market Value (USD billion), by Service Provider, 2025 & 2034
- Figure 41: Asia Pacific Carrier Screening Market Value Share (%), by Service Provider, 2025
- Figure 42: Asia Pacific Carrier Screening Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 43: Asia Pacific Carrier Screening Market Value Share (%), By Country/ Sub-region, 2025
- Figure 44: Latin America Carrier Screening Market Value (USD billion), by Type, 2025 & 2034
- Figure 45: Latin America Carrier Screening Market Value Share (%), by Type, 2025
- Figure 46: Latin America Carrier Screening Market Value (USD billion), By Technology, 2025 & 2034
- Figure 47: Latin America Carrier Screening Market Value Share (%), By Technology, 2025
- Figure 48: Latin America Carrier Screening Market Value (USD billion), by Indication, 2025 & 2034
- Figure 49: Latin America Carrier Screening Market Value Share (%), by Indication, 2025
- Figure 50: Latin America Carrier Screening Market Value (USD billion), by Sample Type, 2025 & 2034
- Figure 51: Latin America Carrier Screening Market Value Share (%), by Sample Type, 2025
- Figure 52: Latin America Carrier Screening Market Value (USD billion), by Service Provider, 2025 & 2034
- Figure 53: Latin America Carrier Screening Market Value Share (%), by Service Provider, 2025
- Figure 54: Latin America Carrier Screening Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 55: Latin America Carrier Screening Market Value Share (%), By Country/ Sub-region, 2025
- Figure 56: Middle East & Africa Carrier Screening Market Value (USD billion), by Type, 2025 & 2034
- Figure 57: Middle East & Africa Carrier Screening Market Value Share (%), by Type, 2025
- Figure 58: Middle East & Africa Carrier Screening Market Value (USD billion), By Technology, 2025 & 2034
- Figure 59: Middle East & Africa Carrier Screening Market Value Share (%), By Technology, 2025
- Figure 60: Middle East & Africa Carrier Screening Market Value (USD billion), by Indication, 2025 & 2034
- Figure 61: Middle East & Africa Carrier Screening Market Value Share (%), by Indication, 2025
- Figure 62: Middle East & Africa Carrier Screening Market Value (USD billion), by Sample Type, 2025 & 2034
- Figure 63: Middle East & Africa Carrier Screening Market Value Share (%), by Sample Type, 2025
- Figure 64: Middle East & Africa Carrier Screening Market Value (USD billion), by Service Provider, 2025 & 2034
- Figure 65: Middle East & Africa Carrier Screening Market Value Share (%), by Service Provider, 2025
- Figure 66: Middle East & Africa Carrier Screening Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 67: Middle East & Africa Carrier Screening Market Value Share (%), By Country/ Sub-region, 2025
- Figure 68: Global Carrier Screening Market Share (%), By Company, 2025
